September 30, 2022 Sophia Vida

Odyssey Health, Inc. Makes Statement Regarding its Concussion Drug Development Program

Las Vegas, NV, Sept. 30, 2022 — McapMediaWire — Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing a unique drug to treat concussion has decided to dissolve its sports advisory board. The sports advisory members have been outspoken advocates for concussion prevention and for the importance of finding responsible … Continue reading “Odyssey Health, Inc. Makes Statement Regarding its Concussion Drug Development Program”